163 related articles for article (PubMed ID: 16683376)
1. Quality control of mammography screening in the Veneto Region. Evaluation of four programs at a local health unit level--analysis of the frequency and diagnostic pattern of interval cancers.
Vettorazzi M; Stocco C; Chirico A; Recanatini S; Saccon S; Mariotto R; Cinquetti S; Moretto T; Sartori P; Stomeo A; Ciatto S
Tumori; 2006; 92(1):1-5. PubMed ID: 16683376
[TBL] [Abstract][Full Text] [Related]
2. Quality assessment of the mammographic screening programme in the Azienda Sanitaria locale Provincia Milano 1 -- analysis of interval cancers and discussion of possible causes of diagnostic error.
Burani R; Caimi F; Maggioni C; Marinoni G; Pellizzoni R; Pirola ME; Villa R; Ciatto S
Radiol Med; 2005 Mar; 109(3):260-7. PubMed ID: 15775895
[TBL] [Abstract][Full Text] [Related]
3. Analysis of interval cancers observed in an Italian mammography screening programme (2000-2006).
Caumo F; Vecchiato F; Pellegrini M; Vettorazzi M; Ciatto S; Montemezzi S
Radiol Med; 2009 Sep; 114(6):907-14. PubMed ID: 19551342
[TBL] [Abstract][Full Text] [Related]
4. Evidence of interval cancer proportional incidence and review from mammography screening programs in Italy.
Ciatto S; Bernardi D; Caumo F
Tumori; 2011; 97(4):419-22. PubMed ID: 21989427
[TBL] [Abstract][Full Text] [Related]
5. Analysis of proportional incidence and review of interval cancer cases observed within the mammography screening programme in Trento province, Italy.
Pellegrini M; Bernardi D; Di Michele S; Tuttobene P; Fantò C; Valentini M; Peterlongo P; Caumo F; Frigerio A; Ciatto S
Radiol Med; 2011 Dec; 116(8):1217-25. PubMed ID: 21744249
[TBL] [Abstract][Full Text] [Related]
6. Interval breast cancers: absolute and proportional incidence and blinded review in a community mammographic screening program.
Carbonaro LA; Azzarone A; Paskeh BB; Brambilla G; Brunelli S; Calori A; Caumo F; Malerba P; Menicagli L; Sconfienza LM; Vadalà G; Brambilla G; Fantini L; Ciatto S; Sardanelli F
Eur J Radiol; 2014 Feb; 83(2):e84-91. PubMed ID: 24369953
[TBL] [Abstract][Full Text] [Related]
7. [Radiologic analysis of interval cancers in the screening program called Florence Woman Project].
Morrone D; Giorgi D; Ciatto S; Ceresatto E; Catarzi S; Roselli Del Turco R
Radiol Med; 2000 Nov; 100(5):321-5. PubMed ID: 11213408
[TBL] [Abstract][Full Text] [Related]
8. Problems, solutions, and perspectives in the evaluation of interval cancers in Italian mammography screening programmes: a position paper from the Italian group for mammography screening (GISMa).
Bucchi L; Frigerio A; Zorzi M; Fedato C; Angiolucci G; Bernardi D; Campari C; Crocetti E; Ferretti S; Giorgi D; Marchisio F; Morrone D; Naldoni C; Petrella M; Ponti A; Ravaioli A; Saguatti G; Santini D; Sassoli de Bianchi P; Serafini M; Vergini V; Giordano L
Epidemiol Prev; 2015; 39(3 Suppl 1):52-7. PubMed ID: 26405777
[TBL] [Abstract][Full Text] [Related]
9. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
10. Quality of mammography screening in the Milan programme: evidence of improved sensitivity based on interval cancer proportional incidence and radiological review.
Elena PM; Nehmat H; Ermes M; Piera C; Maria Q; Guia M; Francesco C; Roberto V; Giovanni F; Isabella G; Stefano C
Breast; 2009 Jun; 18(3):208-10. PubMed ID: 19359176
[TBL] [Abstract][Full Text] [Related]
11. Influence of review design on percentages of missed interval breast cancers: retrospective study of interval cancers in a population-based screening program.
Hofvind S; Skaane P; Vitak B; Wang H; Thoresen S; Eriksen L; Bjørndal H; Braaten A; Bjurstam N
Radiology; 2005 Nov; 237(2):437-43. PubMed ID: 16244251
[TBL] [Abstract][Full Text] [Related]
12. Validating regional Hospital Information System data through comparison with a local cancer register to identify interval cancers of a breast screening program.
Sperati A; Pannozzo F; Giorgi Rossi P; Baiocchi D; Barca A; Borgia P
Eur J Cancer Prev; 2009 Jun; 18(3):212-5. PubMed ID: 19238084
[TBL] [Abstract][Full Text] [Related]
13. Proportional incidence and radiological review of large (T2+) breast cancers as surrogate indicators of screening programme performance.
Ciatto S; Bernardi D; Pellegrini M; Borsato G; Peterlongo P; Gentilini MA; Caumo F; Frigerio A; Houssami N
Eur Radiol; 2012 Jun; 22(6):1250-4. PubMed ID: 22200899
[TBL] [Abstract][Full Text] [Related]
14. Radiological review of prior screening mammograms of screen-detected breast cancer.
Hovda T; Tsuruda K; Hoff SR; Sahlberg KK; Hofvind S
Eur Radiol; 2021 Apr; 31(4):2568-2579. PubMed ID: 33001307
[TBL] [Abstract][Full Text] [Related]
15. A blind review and an informed review of interval breast cancer cases in the Limburg screening programme, the Netherlands.
de Rijke JM; Schouten LJ; Schreutelkamp JL; Jochem I; Verbeek AL
J Med Screen; 2000; 7(1):19-23. PubMed ID: 10807142
[TBL] [Abstract][Full Text] [Related]
16. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
17. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
Taylor R; Page A; Bampton D; Estoesta J; Rickard M
J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
[TBL] [Abstract][Full Text] [Related]
18. National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium.
Lehman CD; Arao RF; Sprague BL; Lee JM; Buist DS; Kerlikowske K; Henderson LM; Onega T; Tosteson AN; Rauscher GH; Miglioretti DL
Radiology; 2017 Apr; 283(1):49-58. PubMed ID: 27918707
[TBL] [Abstract][Full Text] [Related]
19. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
